News
GIFLF
9.53
NaN%
--
Grifols: A Market Setback Turns Into Buying Opportunity
Seeking Alpha · 6d ago
White Falcon Capital Q1 2025 Partner's Letter
Seeking Alpha · 6d ago
Weekly Report: what happened at GIFLF last week (0414-0418)?
Weekly Report · 04/21 11:28
Weekly Report: what happened at GIFLF last week (0407-0411)?
Weekly Report · 04/14 11:17
Weekly Report: what happened at GIFLF last week (0331-0404)?
Weekly Report · 04/07 11:17
Brookfield resumes Grifols takeover talks for €7 billion - report
Seeking Alpha · 04/02 08:01
Weekly Report: what happened at GIFLF last week (0324-0328)?
Weekly Report · 03/31 11:29
Weekly Report: what happened at GIFLF last week (0317-0321)?
Weekly Report · 03/24 11:16
Weekly Report: what happened at GIFLF last week (0310-0314)?
Weekly Report · 03/17 11:28
Weekly Report: what happened at GIFLF last week (0303-0307)?
Weekly Report · 03/10 11:29
Weekly Report: what happened at GIFLF last week (0224-0228)?
Weekly Report · 03/03 11:28
Weekly Report: what happened at GIFLF last week (0217-0221)?
Weekly Report · 02/24 11:28
Weekly Report: what happened at GIFLF last week (0210-0214)?
Weekly Report · 02/17 11:25
Weekly Report: what happened at GIFLF last week (0203-0207)?
Weekly Report · 02/10 11:19
Weekly Report: what happened at GIFLF last week (0127-0131)?
Weekly Report · 02/03 11:24
Weekly Report: what happened at GIFLF last week (0120-0124)?
Weekly Report · 01/27 11:27
Weekly Report: what happened at GIFLF last week (0113-0117)?
Weekly Report · 01/20 11:18
Weekly Report: what happened at GIFLF last week (0106-0110)?
Weekly Report · 01/13 11:19
Weekly Report: what happened at GIFLF last week (1230-0103)?
Weekly Report · 01/06 11:27
Weekly Report: what happened at GIFLF last week (1223-1227)?
Weekly Report · 12/30/2024 11:21
More
Webull provides a variety of real-time GIFLF stock news. You can receive the latest news about Grifols through multiple platforms. This information may help you make smarter investment decisions.
About GIFLF
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.